Article
Takeda drops $300M cash to kick off $1B RNAi alliance with Arrowhead, shooting for first-in-class r
Rating:
0.0
Views:
119
Likes:
1
Library:
1
Twelve years ago, Takeda became the first major Asian pharma company to buy into Alnylam's pioneering RNAi platform with a landmark $1 billion alliance. Two FDA approvals and a slew of new deals for the field later, the Japanese drugmaker is making a new $1.04 billion bet on a rare
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value